Clinical Trials Browser

Phase 2 × Liposarcoma, Myxoid × 30 days × Clear all

NCT03967223 2026-04-17

IGNYTE-ESO

Phase 2 Active not recruiting

Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid